Page last updated: 2024-11-11

ergonovine maleate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ergometrine maleate : A maleate salt resulting form the reaction of equimolar amounts of maleic acid and ergometrine. It is used in the active management of the third stage of labour, and to prevent or treat postpartum of postabortal haemorrhage caused by uterine atony: by maintaining uterine contraction and tone, blood vessels in the uterine wall are compressed and blood flow reduced. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6437065
CHEMBL ID1213135
CHEBI ID31554
SCHEMBL ID317356
MeSH IDM0069657

Synonyms (48)

Synonym
ergometrini hydrogenomaleas
ermetrine
CHEMBL1213135
ergomet
ergometrine hydrogen maleate
ergotocin maleate
ergoline-8-carboxamide, 9,10-didehydro-n-(2-hydroxy-1-methylethyl)-6-methyl-, (8beta(s))-, (z)-2-butenedioate (1:1) (salt)
ergonovine hydrogen maleate
nsc 93752
9,10-didehydro-n-((s)-2-hydroxy-1-methylethyl)-6-methylergoline-8beta-carboxamide maleate (1:1) (salt)
einecs 204-953-5
ergoline-8-carboxamide, 9,10-didehydro-n-((1s)-2-hydroxy-1-methylethyl)-6-methyl-, (8beta)-, (2z)-2-butenedioate (1:1) (salt)
crude ergot
ergoline-8-beta-carboxamide, 9,10-didehydro-n-((s)-2-hydroxy-1-methylethyl)-6-methyl-, maleate (1:1) (salt)
ergonovine maleate
cornocentin
129-51-1
ergometrine maleate
ergometrine maleate (1:1)
ergonovine, maleate (1:1)
nsc-93752
D01163
ergometrine (tn)
ergonovine maleate (usp)
ergometrine maleate (jp17)
ergometrin acid maleate
n-[(2s)-1-hydroxypropan-2-yl]-6-methyl-9,10-didehydroergoline-8beta-carboxamide (2z)-but-2-enedioate
CHEBI:31554 ,
9,10-didehydro-n-((s)-2-hydroxy-1-methylethyl)-6-methylergoline-8beta-carboxamide maleate (1:1)
ergonovine maleate [usp]
ymh3d0zjwv ,
unii-ymh3d0zjwv
ergometrine maleate [mart.]
ergometrine maleate [jan]
ergometrine hydrogen maleate [who-ip]
ergonovine maleate [vandf]
ergonovine maleate [mi]
ergonovine maleate [usp monograph]
ergonovine maleate [usp-rs]
ergometrini hydrogenomaleas [who-ip latin]
9,10-didehydro-n-[(s)-2-hydroxy-1-methylethyl]-6-methylergoline-8beta-carboxamide maleate (1:1) (salt)
ergometrine maleate [ep monograph]
ergometrine maleate [who-dd]
SCHEMBL317356
ergonovine maleate, united states pharmacopeia (usp) reference standard
ergometrine maleate, european pharmacopoeia (ep) reference standard
(6ar,9r)-n-[(2s)-1-hydroxypropan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;(z)-but-2-enedioic acid
Q27114403

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
oxytocicA drug that stimulates contraction of the myometrium. Oxytocics are used to induce labour, obstetric at term, to prevent or control postpartum or postabortion haemorrhage, and to assess foetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (abortifacients).
diagnostic agentA substance administered to aid diagnosis of a disease.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
maleate saltSalts from maleic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID1872390Inhibition of EZH2-EED (unknown origin) protein interaction by FP binding assay2022European journal of medicinal chemistry, Mar-05, Volume: 231Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
AID1872383Binding affinity to EZH2-EED (unknown origin) protein interaction assessed as inhibition constant by FP binding assay2022European journal of medicinal chemistry, Mar-05, Volume: 231Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID190397Evaluated for the Average turns per first 15 minutes after administration of 1 mg/kg intraperitoneally1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines).
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID189493Evaluated for the rat turning after administration of 1 mg/kg intraperitoneally1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines).
AID162618Evaluated for the prolactin inhibition at the dose 50 ug/kg administered intraperitoneally1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines).
AID162619Evaluated for the prolactin inhibition at the dose 50 ug/kg administered intraperitoneally (treatment)1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines).
AID497829Protection against fragile X syndrome phenotypes in laboratory prepared food feeded Fmr1 null mutant Drosophila Fmr1'3/TM6C assessed as homozygous Fmr1-/- embryo viability at 20 uM at 25 degC by flow cytometry relative to untreated homozygous embryos fed 2008Nature chemical biology, Apr, Volume: 4, Issue:4
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila.
AID625295Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID497827Protection against fragile X syndrome phenotypes in Fmr1 null mutant Drosophila Fmr1'3/TM6C assessed as embryo viability at 40 uM at 25 degC by flow cytometry relative to untreated homozygous embryos2008Nature chemical biology, Apr, Volume: 4, Issue:4
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.80 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index51.72 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (25.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]